Sciele Pharma, Inc., of Atlanta and Novo Nordisk Inc., of Denmark, have announced approval for PrandiMet (repaglinide and metformin HCl) tablets, the first and only fixed-dose combination of the ...
Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...
Vietnam Investment Review on MSN
Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently received the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for the Phase II ...
BANGALORE, Jan 6 (Reuters) - Lexicon Pharmaceuticals Inc said it would move ahead with development of a tablet version of its key drug for type-2 diabetes that showed encouraging data in a mid-stage ...
Type 2 diabetes has long been regarded as a chronic, lifelong disease requiring continuous medication in the form of tablets ...
Diabetes drug can also protect heart and liver? Doc answers as Mounjaro slashes man’s insulin by 70%
Young adults are increasingly facing type 2 diabetes risk due to stress and unhealthy habits, even if they appear thin. Doctor highlights this alarming trend. A breakthrough drug, Mounjaro, is showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback